INDIKATION UND APPLIKATION DER BiPAP-THERAPIE

Translated title of the contribution: Indication and application of the BiPAP therapy

H. Becker, U. Brandenburg, J. H. Peter, Hartmut Schneider, P. Weber, P. Von Wichert

Research output: Contribution to journalArticle

Abstract

BiPAP allows the independent adjustment of in- and expiratory pressure. BiPAP may thus be used as a 'physiologic' CPAP if high expiratory pressure values are not tolerated or as a pressure limited ventilator in pts. suffering from central sleep related breathing disorders (SRBD). 12pts with SRBD were treated with nBiPAP: 7 did not tolerate the expiration against the elevated pressure, 4 pts suffering from MSA who still presented relevant CSA or central Hypoventilation during nCPAP and 1 pt. with CSA who did not respond to nCPAP. Mean age was 52.3 y (range 33-70) and mean broca index was 149.6 (range 115-254). RDI before therapy ranged between 33-152/h (mean value 79/h); in the five pts. who tolerated nCPAP, the reduction of the RDI obtained was considered insufficient (RDI during nCPAP: 16-71/h). During BiPAP mean RDI was 6.8/h (range 1 -17) at pressure levels of 10/7 to 16/13 cm H2O (inspiratory/expiratory pressure) in those pts. that had not tolerated CPAP and 7.9/h (range 2-16.5) in the pts. suffering from central SRBD: in one pt. BiPAP could successfully replace a combined treatment with CPAP and IPPV. 11 pts. are using BiPAP for 10 to 25 months (mean value 13.5) now at home. If CPAP proves ineffective (central SRBD, high expiratory pressure) BiPAP constitutes an effective alternative therapy.

Original languageGerman
Pages (from-to)184-188
Number of pages5
JournalPneumologie
Volume47
Issue numberSUPPL. 1
StatePublished - 1993
Externally publishedYes

Fingerprint

Pressure
Sleep
Respiration
Therapeutics
Intermittent Positive-Pressure Ventilation
Social Adjustment
Hypoventilation
Mechanical Ventilators
Complementary Therapies

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Becker, H., Brandenburg, U., Peter, J. H., Schneider, H., Weber, P., & Von Wichert, P. (1993). INDIKATION UND APPLIKATION DER BiPAP-THERAPIE. Pneumologie, 47(SUPPL. 1), 184-188.

INDIKATION UND APPLIKATION DER BiPAP-THERAPIE. / Becker, H.; Brandenburg, U.; Peter, J. H.; Schneider, Hartmut; Weber, P.; Von Wichert, P.

In: Pneumologie, Vol. 47, No. SUPPL. 1, 1993, p. 184-188.

Research output: Contribution to journalArticle

Becker, H, Brandenburg, U, Peter, JH, Schneider, H, Weber, P & Von Wichert, P 1993, 'INDIKATION UND APPLIKATION DER BiPAP-THERAPIE', Pneumologie, vol. 47, no. SUPPL. 1, pp. 184-188.
Becker H, Brandenburg U, Peter JH, Schneider H, Weber P, Von Wichert P. INDIKATION UND APPLIKATION DER BiPAP-THERAPIE. Pneumologie. 1993;47(SUPPL. 1):184-188.
Becker, H. ; Brandenburg, U. ; Peter, J. H. ; Schneider, Hartmut ; Weber, P. ; Von Wichert, P. / INDIKATION UND APPLIKATION DER BiPAP-THERAPIE. In: Pneumologie. 1993 ; Vol. 47, No. SUPPL. 1. pp. 184-188.
@article{3001c3008f8f4589876f06122389069a,
title = "INDIKATION UND APPLIKATION DER BiPAP-THERAPIE",
abstract = "BiPAP allows the independent adjustment of in- and expiratory pressure. BiPAP may thus be used as a 'physiologic' CPAP if high expiratory pressure values are not tolerated or as a pressure limited ventilator in pts. suffering from central sleep related breathing disorders (SRBD). 12pts with SRBD were treated with nBiPAP: 7 did not tolerate the expiration against the elevated pressure, 4 pts suffering from MSA who still presented relevant CSA or central Hypoventilation during nCPAP and 1 pt. with CSA who did not respond to nCPAP. Mean age was 52.3 y (range 33-70) and mean broca index was 149.6 (range 115-254). RDI before therapy ranged between 33-152/h (mean value 79/h); in the five pts. who tolerated nCPAP, the reduction of the RDI obtained was considered insufficient (RDI during nCPAP: 16-71/h). During BiPAP mean RDI was 6.8/h (range 1 -17) at pressure levels of 10/7 to 16/13 cm H2O (inspiratory/expiratory pressure) in those pts. that had not tolerated CPAP and 7.9/h (range 2-16.5) in the pts. suffering from central SRBD: in one pt. BiPAP could successfully replace a combined treatment with CPAP and IPPV. 11 pts. are using BiPAP for 10 to 25 months (mean value 13.5) now at home. If CPAP proves ineffective (central SRBD, high expiratory pressure) BiPAP constitutes an effective alternative therapy.",
author = "H. Becker and U. Brandenburg and Peter, {J. H.} and Hartmut Schneider and P. Weber and {Von Wichert}, P.",
year = "1993",
language = "German",
volume = "47",
pages = "184--188",
journal = "Pneumologie",
issn = "0934-8387",
publisher = "Georg Thieme Verlag",
number = "SUPPL. 1",

}

TY - JOUR

T1 - INDIKATION UND APPLIKATION DER BiPAP-THERAPIE

AU - Becker, H.

AU - Brandenburg, U.

AU - Peter, J. H.

AU - Schneider, Hartmut

AU - Weber, P.

AU - Von Wichert, P.

PY - 1993

Y1 - 1993

N2 - BiPAP allows the independent adjustment of in- and expiratory pressure. BiPAP may thus be used as a 'physiologic' CPAP if high expiratory pressure values are not tolerated or as a pressure limited ventilator in pts. suffering from central sleep related breathing disorders (SRBD). 12pts with SRBD were treated with nBiPAP: 7 did not tolerate the expiration against the elevated pressure, 4 pts suffering from MSA who still presented relevant CSA or central Hypoventilation during nCPAP and 1 pt. with CSA who did not respond to nCPAP. Mean age was 52.3 y (range 33-70) and mean broca index was 149.6 (range 115-254). RDI before therapy ranged between 33-152/h (mean value 79/h); in the five pts. who tolerated nCPAP, the reduction of the RDI obtained was considered insufficient (RDI during nCPAP: 16-71/h). During BiPAP mean RDI was 6.8/h (range 1 -17) at pressure levels of 10/7 to 16/13 cm H2O (inspiratory/expiratory pressure) in those pts. that had not tolerated CPAP and 7.9/h (range 2-16.5) in the pts. suffering from central SRBD: in one pt. BiPAP could successfully replace a combined treatment with CPAP and IPPV. 11 pts. are using BiPAP for 10 to 25 months (mean value 13.5) now at home. If CPAP proves ineffective (central SRBD, high expiratory pressure) BiPAP constitutes an effective alternative therapy.

AB - BiPAP allows the independent adjustment of in- and expiratory pressure. BiPAP may thus be used as a 'physiologic' CPAP if high expiratory pressure values are not tolerated or as a pressure limited ventilator in pts. suffering from central sleep related breathing disorders (SRBD). 12pts with SRBD were treated with nBiPAP: 7 did not tolerate the expiration against the elevated pressure, 4 pts suffering from MSA who still presented relevant CSA or central Hypoventilation during nCPAP and 1 pt. with CSA who did not respond to nCPAP. Mean age was 52.3 y (range 33-70) and mean broca index was 149.6 (range 115-254). RDI before therapy ranged between 33-152/h (mean value 79/h); in the five pts. who tolerated nCPAP, the reduction of the RDI obtained was considered insufficient (RDI during nCPAP: 16-71/h). During BiPAP mean RDI was 6.8/h (range 1 -17) at pressure levels of 10/7 to 16/13 cm H2O (inspiratory/expiratory pressure) in those pts. that had not tolerated CPAP and 7.9/h (range 2-16.5) in the pts. suffering from central SRBD: in one pt. BiPAP could successfully replace a combined treatment with CPAP and IPPV. 11 pts. are using BiPAP for 10 to 25 months (mean value 13.5) now at home. If CPAP proves ineffective (central SRBD, high expiratory pressure) BiPAP constitutes an effective alternative therapy.

UR - http://www.scopus.com/inward/record.url?scp=0027533859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027533859&partnerID=8YFLogxK

M3 - Article

C2 - 8497477

AN - SCOPUS:0027533859

VL - 47

SP - 184

EP - 188

JO - Pneumologie

JF - Pneumologie

SN - 0934-8387

IS - SUPPL. 1

ER -